JOA scores | Experimental group | Control group | t/t' | P |
---|---|---|---|---|
Subjective symptoms | ||||
Preoperation | 0.69 ± 0.05 | 0.71 ± 0.02 | 0.472 | 0.846 |
3 days after operation | 3.61 ± 0.82* | 3.01 ± 0.63* | 0.562 | 0.793 |
t = 3.636, P < 0.05 | t = 3.586 P < 0.05 | |||
Last follow-up | 8.31 ± 0.32* | 7.75 ± 0.90* | 0.592 | 0.771 |
t = 4.543, P < 0.05 | t = 4.562, P < 0.05 | |||
Clinical signs | ||||
Preoperation | 4.23 ± 1.01 | 4.21 ± 1.03 | 0.381 | 0.996 |
3 days after operation | 5.42 ± 0.38* | 5.07 ± 0.84* | 0.672 | 0.702 |
t = 3.072, P < 0.05 | t = 3.062, P < 0.05 | |||
Last follow-up | 5.53 ± 0.47* | 5.39 ± 0.53* | 0.432 | 0.853 |
t = 4.252, P < 0.05 | t = 4.322, P < 0.05 | |||
Daily activity limitation | ||||
Preoperation | 5.07 ± 1.98 | 5.05 ± 1.95 | 0.390 | 0.931 |
3 days after operation | 8.47 ± 2.96* | 8.04 ± 2.37* | 0.424 | 0.858 |
t = 3.241, P < 0.05 | t = 3.211, P < 0.05 | |||
Last follow-up | 12.73 ± 1.25* t = 4.562, P < 0.05 | 12.02 ± 1.46* t = 4.886, P < 0.05 | 0.521 | 0.799 |
Bladder function | ||||
Preoperation | − 4.59 ± 1.82 | − 4.63 ± 1.21 | 0.411 | 0.864 |
3 days after operation | − 0.74 ± 0.06* | − 1.02 ± 0.42* | 5.213 | 0.011* |
t = 4.901, P < 0.05 | t = 3.021, P < 0.05 | |||
Last follow-up | − 0.29 ± 0.02* | − 0.31 ± 0.05* | 0.872 | 0.056 |
t = 5.625, P < 0.05 | t = 4.952, P < 0.05 |